Cancer Q&A: Understanding the Role and Reality of CAR T-Cell Therapy for Non-Hodgkin Lymphoma

Cancer Q&A: Understanding the Role and Reality of CAR T-Cell Therapy for Non-Hodgkin Lymphoma

Register here

Wednesday, October 22, 6:00 p.m. – 7:00 p.m. ET

In partnership with Research To Practice^®, this special webinar is designed to educate patients about CAR T-cell therapy for non-Hodgkin lymphoma. Participants will learn about what is important in a diagnosis of non-Hodgkin lymphoma, key factors in treatment decision-making and what side effects may be encountered. Led by nationally renowned medical oncologist Dr. Neil Love, this medical webinar is designed to provide accessible information for patients and their friends or family members.

Key Takeaways

• Understand how CAR T-cell therapy works and what the treatment experience is like for patients
• Learn about available CAR T-cell therapy options for non-Hodgkin lymphoma
• Know about potential side effects of CAR T-cell therapy and what is done to prevent and manage them
• Contribute to shared decision-making between patients and their healthcare providers

Faculty:

Jeremy S. Abramson, MD, MMSc, Director, Center for Lymphoma, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Loretta J. Nastoupil, MD, Oncologist, Southwest Oncology, CommonSpirit Mercy Hospital, Durango, Colorado

Moderator:

Neil Love, MD, Research To Practice, Miami, Florida

Submit your questions in advance for the faculty to address during the webinar here.

A Live Webinar for Patients, Developed in Partnership with Research To Practice®.